Literature DB >> 6809782

Chronic pulsatile low dose GnRH therapy for induction of testosterone production and spermatogenesis in a man with secondary hypogonadotropic hypogonadism.

G Skarin, S J Nillius, L Wibell, L Wide.   

Abstract

Prolonged intermittent treatment with low doses of GnRH was given to a 23-yr-old man with secondary hypogonadotropic hypogonadism. The patient had experienced sudden onset of diabetes insipidus followed by progressive decrease of gonadotropins and gonadal function. Modern radiological techniques did not reveal any organic genesis. A small portable computerized infusion pump connected to a sc catheter was used for the 220-day GnRH therapy. One microgram gnRH was administered every 90 min during the first 90 days and 5 micrograms GnRH every 90 min during the following 130 days. During the prolonged GnRH treatment testosterone secretion normalized, libido and potency improved, and ejaculation returned. Spermatogenesis became close to normal and the subject's wife became pregnant after 181 days of treatment. The prolonged treatment with the small infusion pump was well accepted and did not interfere with the patient's daily life activations. Thus, chronic pulsatile low dose GnRH treatment can restore normal pituitary-gonadal function in idiopathic male hypogonadotropic hypogonadism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6809782     DOI: 10.1210/jcem-55-4-723

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Isolated hypogonadotropic hypogonadism in male identical twins.

Authors:  F Geola; J M Hershman
Journal:  West J Med       Date:  1989-01

Review 2.  Update on pulsatile luteinizing hormone-releasing hormone therapy in males with idiopathic hypogonadotropic hypogonadism and delayed puberty.

Authors:  M Giusti; P Cavagnaro
Journal:  J Endocrinol Invest       Date:  1991-05       Impact factor: 4.256

3.  Studies on six patients with isolated hypogonadotropic hypogonadism--the response to a short course of pulsatile LHRH.

Authors:  G C Hawthorne; B Sheridan; H Leslie; A B Atkinson
Journal:  Ir J Med Sci       Date:  1985-06       Impact factor: 1.568

Review 4.  Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.

Authors:  B J Furr; J R Woodburn
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

Review 5.  Treatment of male fertility disturbances. Current concepts.

Authors:  W B Schill; M Michalopoulos
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

Review 6.  The role of ovarian ablation in the adjuvant therapy of breast cancer.

Authors:  Sing-Huang Tan; Antonio C Wolff
Journal:  Curr Oncol Rep       Date:  2008-01       Impact factor: 5.075

7.  Sexual maturation of the hypothalamus: pathophysiological aspects and clinical implications.

Authors:  M G Forest
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.